SOTRADECOL DIN 02347776
Health Canada record
| Active ingredient(s) | SODIUM TETRADECYL SULFATE 1 % |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | C05BB04 SODIUM TETRADECYL SULPHATE |
| Original market date | |
| Current status date | 03-Nov-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM TETRADECYL SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00511234 | TROMBOJECT 1% | OMEGA LABORATORIES LIMITED | Solution | SODIUM TETRADECYL SULFATE 10 MG | Marketed |
| 00511226 | TROMBOJECT 3% | OMEGA LABORATORIES LIMITED | Solution | SODIUM TETRADECYL SULFATE 30 MG | Marketed |
| 02347784 | SOTRADECOL | MYLAN PHARMACEUTICALS ULC | Solution | SODIUM TETRADECYL SULFATE 3 % | Cancelled Pre Market |
| 00363332 | TROMBOVAR INJ 1% | THERAPEX DIVISION DE E-Z-EM CANADA INC | Solution | SODIUM TETRADECYL SULFATE 1 % | Cancelled Post Market |
| 00363340 | TROMBOVAR INJ 3% | THERAPEX DIVISION DE E-Z-EM CANADA INC | Solution | SODIUM TETRADECYL SULFATE 3 % | Cancelled Post Market |
International API supply for SODIUM TETRADECYL SULFATE
4 active FDA Drug Master Files.
Request a quote for SOTRADECOL